aTYR PHARMA ATYR
NASDAQ ATYR
$0.17 +0.00 (+0.00%)
At close: Oct 22, 2026 · 4:00 PM EDT

aTYR PHARMA (ATYR) Selling, General & Administrative (2014 - 2026)

Updated

aTYR PHARMA (ATYR) recorded Selling, General & Administrative of $4.13 million in Q2 2026, down 16.1% from $4.93 million a year earlier but up 0.3% from the prior quarter.

Analysis

aTYR PHARMA (ATYR) Selling, General & Administrative (2014 - 2026) Analysis & Trends

On a TTM basis, aTYR PHARMA's Selling, General & Administrative came in at $16.96 million as of Jun 30, 2026, up 7.2% year-over-year; for FY2025, it was $17.6 million, up 27.7% from FY2024.

  • Annual Selling, General & Administrative has a five-year compound annual growth rate of 14.2% (FY2020 to FY2025).
  • Across earlier years, Selling, General & Administrative came in at $13.78 million in FY2024 (+6.1%), $12.98 million in FY2023 (-7.2%), $13.98 million in FY2022 (+30.1%) and $10.75 million in FY2021 (+18.5%).
  • Quarterly Selling, General & Administrative has ranged from $2.59 million in Q3 2021 to $4.93 million in Q2 2025 over the past five years.
  • On a year-over-year basis, Selling, General & Administrative rose in seven of the last eight quarters, with growth averaging 17.4%.
  • Peak year-over-year performance for Selling, General & Administrative in the last five years was growth of 47.5% in Q2 2025, against a decline of 26.9% in Q3 2023 at the low end.
  • Per Business Quant, the preceding three quarters came in at $4.12 million (Q1 2026), $3.91 million (Q4 2025) and $4.81 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,142.35 Bn 1,110.94 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 635.52 Bn 555.38 Bn 17.30 Bn 6.29 Bn
3 AbbVie 501.09 Bn 474.20 Bn 12.70 Bn 3.63 Bn
4 Merck 356.35 Bn 310.72 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 300.53 Bn 264.52 Bn 11.24 Bn 3.24 Bn
6 Astrazeneca 263.02 Bn 236.71 Bn 12.86 Bn 5.65 Bn
7 Amgen 238.00 Bn 193.40 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 194.35 Bn 168.55 Bn 6.22 Bn 1.92 Bn
9 Pfizer 170.37 Bn 117.02 Bn 10.94 Bn 3.41 Bn
10 aTYR PHARMA 15.76 Mn -277.06 Mn - 4.13 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 4.13 Mn
Mar 31, 2026 4.12 Mn
Dec 31, 2025 3.91 Mn
Sep 30, 2025 4.81 Mn
Jun 30, 2025 4.93 Mn
Mar 31, 2025 3.96 Mn
Dec 31, 2024 3.59 Mn
Sep 30, 2024 3.34 Mn
Jun 30, 2024 3.34 Mn
Mar 31, 2024 3.51 Mn
Dec 31, 2023 3.20 Mn
Sep 30, 2023 2.65 Mn
Jun 30, 2023 3.72 Mn
Mar 31, 2023 3.41 Mn
Dec 31, 2022 3.43 Mn
Sep 30, 2022 3.63 Mn
Jun 30, 2022 3.45 Mn
Mar 31, 2022 3.48 Mn
Dec 31, 2021 2.69 Mn
Sep 30, 2021 2.59 Mn
API Access

aTYR PHARMA Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=ATYR&period=max&api_key=YOUR_API_KEY